SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-008914
Filing Date
2019-10-16
Accepted
2019-10-16 06:51:26
Documents
13
Period of Report
2019-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20191015x8k.htm   iXBRL 8-K 46077
2 EX-99.1 bpmc-20191015ex9915e7ac7.htm EX-99.1 36995
  Complete submission text file 0001558370-19-008914.txt   215192

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20191015.xsd EX-101.SCH 3296
4 EX-101.LAB bpmc-20191015_lab.xml EX-101.LAB 15503
5 EX-101.PRE bpmc-20191015_pre.xml EX-101.PRE 10532
6 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20191015x8k_htm.xml XML 4725
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 191151955
SIC: 2834 Pharmaceutical Preparations